Entity Details

Primary name ALG6_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9Y672
EntryNameALG6_HUMAN
FullNameDolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase
TaxID9606
Evidenceevidence at protein level
Length507
SequenceStatuscomplete
DateCreated2002-05-27
DateModified2021-06-02

Ontological Relatives

GenesALG6

GO terms

Show/Hide Table
GOName
GO:0005789 endoplasmic reticulum membrane
GO:0006487 protein N-linked glycosylation
GO:0006488 dolichol-linked oligosaccharide biosynthetic process
GO:0006490 oligosaccharide-lipid intermediate biosynthetic process
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0042281 dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity
GO:0046527 glucosyltransferase activity

Subcellular Location

Show/Hide Table
Subcellular Location
Endoplasmic reticulum membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR004856 Glycosyl transferase, ALG6/ALG8FamilyFamily
IPR039488 Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferaseFamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
603147 OMIMCongenital disorder of glycosylation 1C (CDG1C)A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. The disease is caused by variants affecting the gene represented in this entry.

Interactions

0 interactions

InteractorPartnerSourcesPublicationsLink